Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

Brunet, M.; van Gelder, T.; Åsberg, A.; Haufroid, V.; Hesselink, D.; Langman, L.; Lemaître, F.; Marquet, P.; Seger, C.; Shipkova, M.; Vinks, A.; Wallemacq, P.; Wieland, E.; Woillard, J.; Barten, M.; Budde, K.; Colom, H.; Dieterlen, M.; Elens, L.; Johnson-Davis, K.; Kunicki, P.; Macphee, I.; Masuda, S.; Mathew, B.; Millán, O.; Mizuno, T.; Moes, D.; Monchaud, C.; Noceti, Ofelia; Pawiński, T.; Picard, N.; V. van Schaik, R.; Sommerer, C.; T. Vethe, N.; D. de Winter, B.; Christians, U.; Bergan, S.

doi:10.1097/FTD.0000000000000640

Public

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

Shared by NobleBlocks on Jun 1, 2019 • 12:00 AM UTC

Authors:

M. Brunet

T. van Gelder

A. Åsberg

Abstract

Abstract: Ten years ago, a consensus report on the optimization of tacrolimus was published in this journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicity (IATDMCT) decided to issue an updated consensus...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!